Search by Drug Name or NDC
NDC 55150-0329-25 MEDROXYPROGESTERONE ACETATE 150 mg/mL Details
MEDROXYPROGESTERONE ACETATE 150 mg/mL
MEDROXYPROGESTERONE ACETATE is a INTRAMUSCULAR INJECTION, SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eugia US LLC. The primary component is MEDROXYPROGESTERONE ACETATE.
MedlinePlus Drug Summary
Medroxyprogesterone intramuscular (into a muscle) injection and medroxyprogesterone subcutaneous (under the skin) injection are used to prevent pregnancy. Medroxyprogesterone subcutaneous injection is also used to treat endometriosis (a condition in which the type of tissue that lines the uterus (womb) grows in other areas of the body and causes pain, heavy or irregular menstruation [periods], and other symptoms). Medroxyprogesterone is in a class of medications called progestins. It works to prevent pregnancy by preventing ovulation (the release of eggs from the ovaries). Medroxyprogesterone also thins the lining of the uterus. This helps to prevent pregnancy in all women and slows the spread of tissue from the uterus to other parts of the body in women who have endometriosis. Medroxyprogesterone injection is a very effective method of birth control but does not prevent the spread of human immunodeficiency virus (HIV, the virus that causes acquired immunodeficiency syndrome [AIDS]) or other sexually transmitted diseases.
Related Packages: 55150-0329-25Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Medroxyprogesterone Injection
Product Information
| NDC | 55150-0329 |
|---|---|
| Product ID | 55150-329_c9f7d676-5c95-4cc3-b5fb-bc3e8d545847 |
| Associated GPIs | |
| GCN Sequence Number | 017584 |
| GCN Sequence Number Description | medroxyprogesterone acetate VIAL 150 MG/ML INTRAMUSC |
| HIC3 | G8C |
| HIC3 Description | CONTRACEPTIVES,INJECTABLE |
| GCN | 11251 |
| HICL Sequence Number | 001442 |
| HICL Sequence Number Description | MEDROXYPROGESTERONE ACETATE |
| Brand/Generic | Generic |
| Proprietary Name | MEDROXYPROGESTERONE ACETATE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | MEDROXYPROGESTERONE ACETATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SUSPENSION |
| Route | INTRAMUSCULAR |
| Active Ingredient Strength | 150 |
| Active Ingredient Units | mg/mL |
| Substance Name | MEDROXYPROGESTERONE ACETATE |
| Labeler Name | Eugia US LLC |
| Pharmaceutical Class | Progesterone Congeners [CS], Progestin [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA212824 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 55150-0329-25 (55150032925)
| NDC Package Code | 55150-329-25 |
|---|---|
| Billing NDC | 55150032925 |
| Package | 25 VIAL, SINGLE-DOSE in 1 CARTON (55150-329-25) / 1 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2022-08-22 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |